Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract prospective randomized study

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 2, 2014, Pages 237-243

  Ling, Zhiyu ^a   Liu, Zengzhang ^a   Su, Li ^a   Zipunnikov, Vadim ^b   Wu, Jinjin ^a   Du, Huaan ^a   Woo, Kamsang ^c   Chen, Shaojie ^a   Zhong, Bin ^d   Lan, Xianbin ^a   Fan, Jinqi ^a   Xu, Yanping ^a   Chen, Weijie ^a   Yin, Yuehui ^a   Nazarian, Saman ^e   Zrenner, Bernhard ^f  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d The Fifth People's Hospital of Chongqing   (China)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Krankenhaus Landshut Achdorf   (Germany)

Author keywords

Anti arrhythmia agents; Catheter ablation

Indexed keywords

METOPROLOL; PROPAFENONE;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; CATHETER ABLATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEMATOMA; HUMAN; HYPOTENSION; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINUS BRADYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PREMATURE COMPLEXES;

EID: 84900452775     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000805     Document Type: Article

References (26)

1. Prystowsky EN, Padanilam BJ, Joshi S, Fogel RI. Ventricular arrhythmias in the absence of structural heart disease. J Am Coll Cardiol. 2012;59: 1733-1744.
2. Santangeli P, Pieroni M, Dello Russo A, Casella M, Pelargonio G, Di Biase L, Macchione A, Burkhardt JD, Bellocci F, Santarelli P, Tondo C, Natale A. Correlation between signal-averaged ECG and the histologic evaluation of the myocardial substrate in right ventricular outflow tract arrhythmias. Circ Arrhythm Electrophysiol. 2012;5:475-483.
3. Herczku C, Berruezo A, Andreu D, Fernández-Armenta J, Mont L, Borràs R, Arbelo E, Tolosana JM, Trucco E, Ríos J, Brugada J. Mapping data predictors of a left ventricular outflow tract origin of idiopathic ventricular tachycardia with V3 transition and septal earliest activation. Circ Arrhythm Electrophysiol. 2012;5:484-491.
4. Cole CR, Marrouche NF, Natale A. Evaluation and management of ventricular outflow tract tachycardias. Card Electrophysiol Rev. 2002;6:442-447.
5. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114:e385-e484.
6. Van Herendael H, Garcia F, Lin D, Riley M, Bala R, Cooper J, Tzou W, Hutchinson MD, Verdino R, Gerstenfeld EP, Dixit S, Callans DJ, Tschabrunn CM, Zado ES, Marchlinski FE. Idiopathic right ventricular arrhythmias not arising from the outflow tract: prevalence, electrocardiographic characteristics, and outcome of catheter ablation. Heart Rhythm. 2011;8:511-518.
7. Morady F, Kadish AH, DiCarlo L, Kou WH, Winston S, deBuitlier M, Calkins H, Rosenheck S, Sousa J. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation. 1990;82:2093-2099.
8. Bogun F, Crawford T, Reich S, Koelling TM, Armstrong W, Good E, Jongnarangsin K, Marine JE, Chugh A, Pelosi F, Oral H, Morady F. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm. 2007;4:863-867.
9. Yarlagadda RK, Iwai S, Stein KM, Markowitz SM, Shah BK, Cheung JW, Tan V, Lerman BB, Mittal S. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation. 2005;112:1092-1097.
10. Takemoto M, Yoshimura H, Ohba Y, Matsumoto Y, Yamamoto U, Mohri M, Yamamoto H, Origuchi H. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol. 2005;45:1259-1265.
11. Ito S, Tada H, Naito S, Kurosaki K, Ueda M, Hoshizaki H, Miyamori I, Oshima S, Taniguchi K, Nogami A. Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol. 2003;14:1280-1286.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
13. Duffee DF, Shen WK, Smith HC. Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy. Mayo Clin Proc. 1998;73:430-433.
14. Wijnmaalen AP, Delgado V, Schalij MJ, van Huls van Taxis CF, Holman ER, Bax JJ, Zeppenfeld K. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction. Heart. 2010;96:1275-1280.
15. Mountantonakis SE, Frankel DS, Gerstenfeld EP, Dixit S, Lin D, Hutchinson MD, Riley M, Bala R, Cooper J, Callans D, Garcia F, Zado ES, Marchlinski FE. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm. 2011;8:1608-1614.
16. Krittayaphong R, Sriratanasathavorn C, Dumavibhat C, Pumprueg S, Boonyapisit W, Pooranawattanakul S, Phrudprisan S, Kangkagate C. Electrocardiographic predictors of long-term outcomes after radiofrequency ablation in patients with right-ventricular outflow tract tachycardia. Europace. 2006;8:601-606.
17. El-Menyar AA, Abdou SM. Impact of left bundle branch block and activation pattern on the heart. Expert Rev Cardiovasc Ther. 2008;6:843-857.
18. Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E, Chugh A, Pelosi F Jr, Crawford T, Oral H, Morady F, Bogun F. The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm. 2011;8:1046-1049.
19. Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K, Rosen B, Lima JA, Calkins H, Bluemke DA. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45:98-103.
20. Nazarian S, Bluemke DA, Halperin HR. Applications of cardiac magnetic resonance in electrophysiology. Circ Arrhythm Electrophysiol. 2009;2:63-71.
21. Globits S, Kreiner G, Frank H, Heinz G, Klaar U, Frey B, Gössinger H. Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation. 1997;96:2633-2640.
22. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
23. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993;270:1589-1595.
24. Haïssaguerre M, Shah DC, Jaïs P, Shoda M, Kautzner J, Arentz T, Kalushe D, Kadish A, Griffith M, Gaïta F, Yamane T, Garrigue S, Hocini M, Clémenty J. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet. 2002;359:677-678.
25. Igarashi M, Tada H, Kurosaki K, Yamasaki H, Akiyama D, Sekiguchi Y, Kuroki K, Machino T, Murakoshi N, Nakata Y, Kuga K, Nogami A, Aonuma K. Electrocardiographic determinants of the polymorphic QRS morphology in idiopathic right ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol. 2012;23:521-526.
26. Noda T, Shimizu W, Taguchi A, Aiba T, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol. 2005;46:1288-1294.